What type of study is this?

This is a In Vitro Study study.

September 18, 2025Acta Medica BulgaricaOpen Access

Protective Effects of Quercetin, Curcumin and Resveratrol in an in Vitro Model of Doxorubicin-Induced Cardiotoxicity

View Full Paper

Ask AI

Bookmark

Authors

This in vitro analysis evaluates how quercetin and curcumin enhance H9c2 cell viability, suggesting they mitigate doxorubicin's cardiotoxic effects.

Quercetin and curcumin significantly increased H9c2 cell viability following doxorubicin treatment, indicating protective effects.
Cell viability assessment shows that at 0.25 μM doxorubicin, quercetin and curcumin markedly improve outcomes in H9c2 cells.
The study utilizes an in vitro model to examine the cardioprotective effects of antioxidants against doxorubicin-induced toxicity.
Findings highlight the potential of natural antioxidants quercetin and curcumin in counteracting drug-induced cardiac damage.

Stoyanov et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

September 18, 2025Acta Medica BulgaricaOpen Access

View Full Paper

Ask AI

Bookmark

Authors

This in vitro analysis evaluates how quercetin and curcumin enhance H9c2 cell viability, suggesting they mitigate doxorubicin's cardiotoxic effects.

Quercetin and curcumin significantly increased H9c2 cell viability following doxorubicin treatment, indicating protective effects.
Cell viability assessment shows that at 0.25 μM doxorubicin, quercetin and curcumin markedly improve outcomes in H9c2 cells.
The study utilizes an in vitro model to examine the cardioprotective effects of antioxidants against doxorubicin-induced toxicity.
Findings highlight the potential of natural antioxidants quercetin and curcumin in counteracting drug-induced cardiac damage.

Stoyanov et al. (2025) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark